Steminent Biotherapeutics, Inc (TPEX:7729)

Market Cap	1.17B
Revenue	n/a
Net Income	n/a
Shares Out	56.11M
EPS	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	20,010
Average Volume	38,577
Open	20.90
Previous Close	20.80
Day's Range	20.50 - 21.10
52-Week Range	15.25 - 30.30
Beta	n/a
RSI	44.20
Earnings Date	n/a

About Steminent Biotherapeutics

Steminent Biotherapeutics, Inc., a stem cell research and development company, develops and manufactures novel cellular therapeutics for the treatment of diseases with unmet or under-served medical needs. The company focuses on Stemchymal portfolio of cell therapy research and development programs based on allogeneic stem cells that target neurodegenerative and other degenerative diseases. Its product pipeline includes various pre-clinical and clinical stage therapeutic programs for the treatment of spinocerebellar ataxia (PolyQ SCA), osteoarth...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2009
• Country: Taiwan
• Stock Exchange: Taipei Exchange
• Ticker Symbol: 7729